Gene Therapy; Helps Treat or Prevent Disease by Correcting the Underlying Genetic Problem

Gene Therapy
Gene Therapy

Gene Therapy is a technique that modifies an individual's genes to treat or cure disease. A gene therapy replaces a faulty gene or adds a new gene in an attempt to cure disease or improve the body's ability to fight a disease. It is a logical way to treat rare genetic diseases; cure a single gene defect by introducing a 'correct' gene. A therapy involves altering the genes inside body's cells in an effort to treat or stop disease. Gene therapy is particularly relevant to rare disease patients, as more than 80% of rare diseases have a known monogenic (single-gene) cause.

Gene Therapy can help prevent or cure a wide range of diseases, such as cancer, diabetes, heart disease, cystic fibrosis, AIDS, and hemophilia, among others. Gene transfer is a new treatment modality that introduces new genes into a cancerous cell or the surrounding tissue to cause cell death or slow the growth of the cancer. Cancer types, which have been targeted with gene therapy, include breast, lung, brain, liver, skin, colorectal, bladder, prostate, head and neck, ovarian, pancreatic, and renal cancer, among others.

Thus, with the increase in prevalence of cancer across the globe, the use of Gene Therapy Market is also increase with a rapid pace. For example, according to the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. The Food and Drug Administration (FDA) has approved Abecma, a cell-based gene therapy to treat adult patients with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

Moreover, Boston Children's Hospital offers two Gene Therapy treatments approved by the U.S. FDA; Zolgensma for spinal muscular atrophy (SMA) and KYMRIAH CAR T-cell therapy for relapsed acute lymphoblastic leukemia (ALL). In short, gene therapy brings the latest research into genetic and cell-based technologies to treat variety of disease.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more